Health Technology Assessments

Health Technology Assessments (HTAs) are a comprehensive systematic review and critical analysis of available evidence for A SINGLE medical technology for which there are several published clinical trials and a substantial body of evidence. This report details an entire technology class for which there are one or more indications or patient populations in use.

Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.

Micro-Ultrasound for Diagnosis of Prostate Cancer

Focus of the Report: In its application to prostate biopsy, micro-ultrasound (mUS), also known as high-resolution ultrasound (US), not only provides guidance for the biopsy needle but also allows identification of features that cannot be revealed by conventional US. Thus, mUS has the potential to identify cancerous lesions that might otherwis…

Micro-Ultrasound for Diagnosis of Prostate Cancer

Focus of the Report: In its application to prostate biopsy, micro-ultrasound (mUS), also known as high-resolution ultrasound (US), not only provides guidance for the biopsy needle but also allows identification of features that cannot be revealed by conventional US. Thus, mUS has the potential to identify cancerous lesions that might otherwis…

Botulinum Toxin for Treatment of Raynaud Phenomenon

Focus of the Report: For use of botulinum toxin (BTX) for Raynaud phenomenon (RP).

Technology Description: BTX has been investigated as a treatment for various chronic painful conditions because of its potential to reduce muscle tension and modulate pain receptor activity in the central nervous system. For the treatment of RP, there is currently no sta…

Magnetic Resonance Elastography for Prognosis of Liver Disease Progression

Focus of the Report: Magnetic resonance elastography (MRE) is a diagnostic test for assessing hepatic fibrosis, a form of liver damage that occurs when healthy tissue is replaced by stiff, fibrous scar tissue. This report focuses on MRE for prediction of serious potential consequences of liver disease such as development of cirrhosis or liver…